CenterPoint Energy heads into its third-quarter report with a peculiar mismatch. Management spent its last call describing a utility whose growth runway keeps getting longer, yet the stock has slipped 6.9% since then while the S&P 500 gained 3.3%. That 10-point gap suggests the market is not doubting the pipeline so much as questioning how quickly a 10-year capital story turns into earnings per share. The October 27 report, due before the open, is a chance to narrow that gap or widen it.
The near-term numbers are unremarkable by design. Analysts expect $0.50 per share, matching the year-ago figure, on revenue of about $2.16 billion, up 8.7%. Flat earnings against higher revenue is the kind of pattern that tends to reflect timing in regulatory recovery, financing costs, and the drag of a heavy build-out more than any weakness in demand. The Earnings Whisper of $0.52 sits a couple of cents above consensus, a modest sign that some investors expect a small beat, though hardly a demanding bar. For the full year, management has said it expects to land at least at the midpoint of its $1.89 to $1.91 range, and the Street's $1.91 sits at the top of that range. So consensus is already leaning toward the upper end. A quarter that keeps the company on pace for $1.91 would validate that view, while any wording that steers back toward $1.90 would read as a quiet disappointment.
The more consequential content lies beyond the quarter's EPS. Last quarter, CenterPoint said Houston Electric had 14 GW of ERCOT batch-zero-eligible large-load demand, up from 12.2 GW the prior quarter and 7.5 GW at year-end. That figure is more than 65% of the system's 21 GW peak, with nearly all of it expected to be energized by 2030. The capital plan climbed again, to $66.7 billion, and the three-year Houston Electric rate base growth target jumped to more than 18% from over 11%. Management also insisted all of this could be funded without new equity. What would confirm the story is further progress converting eligible load into signed, energizing customers, and clarity on the 3 GW of submissions that failed ERCOT study approval. The roughly $700 million tied to that load was deliberately left out of the plan, so a favorable resolution is a potential upside lever. The comprehensive transmission study, including 765kV projects that face legislative and routing scrutiny, was pushed to the second half of the year. This report is a natural place to deliver it, and another delay would chip at credibility.
The balance sheet is the other test. Adjusted FFO to debt improved to 13.4% from 12.5%, and management flagged roughly 30 basis points more in the third quarter from a minimum tax refund. The Ohio gas utility sale, worth about $2.4 billion in net proceeds, was slated to close October 1. Confirmation of both would support the no-equity claim, especially with Moody's still holding a negative outlook. Investors should also watch the Indiana discussion, where new generation and transmission spending would likely require some equity, unlike the Texas plan.
Sentiment has improved to modestly bullish from slightly bearish heading into last quarter, even as the stock fell. Shares at $40.55 sit below the 200-day moving average of $41.41 and in the lower half of a wide post-earnings range between $36.37 and $45.26, leaving room for a rerating if the story holds. The central question is whether CenterPoint can show that its swelling load and capital figures are financeable and on schedule while keeping 2026 earnings at the top of its range. Do that, and the recent selloff looks like a disconnect. Stumble on transmission timing or credit, and the market's caution will look justified.